- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
1 Online-Ressource.
- Language
-
Englisch
- Bibliographic citation
-
Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells ; volume:627 ; number:8004 ; day:28 ; month:2 ; year:2024 ; pages:646-655 ; date:3.2024
Nature; 627, Heft 8004 (28.2.2024), 646-655, 3.2024
- Creator
-
Guan, Xiangnan
Hu, Ruozhen
Choi, Yoonha
Srivats, Shyam
Nabet, Barzin Y.
Silva, John
McGinnis, Lisa
Hendricks, Robert
Nutsch, Katherine
Banta, Karl L.
Duong, Ellen
Dunkle, Alexis
Chang, Patrick S.
Han, Chia-Jung
Mittman, Stephanie
Molden, Nandini
Daggumati, Pallavi
Connolly, Wendy
Johnson, Melissa
Rodríguez-Abreu, Delvys
Cho, Byoung C.
Italiano, Antoine
Gil-Bazo, Ignacio
Felip, Enriqueta
Mellman, Ira
Mariathasan, Sanjeev
Shames, David S.
Meng, Raymond
Chiang, Eugene Y.
Johnston, Robert J.
Patil, Namrata S.
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1038/s41586-024-07121-9
- URN
-
urn:nbn:de:101:1-2408082100470.974491810044
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:44 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Guan, Xiangnan
- Hu, Ruozhen
- Choi, Yoonha
- Srivats, Shyam
- Nabet, Barzin Y.
- Silva, John
- McGinnis, Lisa
- Hendricks, Robert
- Nutsch, Katherine
- Banta, Karl L.
- Duong, Ellen
- Dunkle, Alexis
- Chang, Patrick S.
- Han, Chia-Jung
- Mittman, Stephanie
- Molden, Nandini
- Daggumati, Pallavi
- Connolly, Wendy
- Johnson, Melissa
- Rodríguez-Abreu, Delvys
- Cho, Byoung C.
- Italiano, Antoine
- Gil-Bazo, Ignacio
- Felip, Enriqueta
- Mellman, Ira
- Mariathasan, Sanjeev
- Shames, David S.
- Meng, Raymond
- Chiang, Eugene Y.
- Johnston, Robert J.
- Patil, Namrata S.
- SpringerLink (Online service)
Other Objects (12)
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1
Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Development of a bispecific antibody targeting PD-L1 and TIGIT with optimal cytotoxicity
PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Development of a novel T cell engaging antibody derivative for local PD-1/PD-L1 immune checkpoint blockade in acute myeloid leukemia
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1
Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Development of a bispecific antibody targeting PD-L1 and TIGIT with optimal cytotoxicity
PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors
Development of a novel T cell engaging antibody derivative for local PD-1/PD-L1 immune checkpoint blockade in acute myeloid leukemia
Publisher Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Author Correction: Anti-TIGIT antibody improves PD-L1 blockade through myeloid and Treg cells
Distinct PD-L1 binding characteristics of therapeutic monoclonal antibody durvalumab
BMSCs improve TNBS-induced colitis in rats by inducing Treg differentiation by expressing PD-L1
Quantitative PET imaging of PD-L1 expression in xenograft and syngeneic tumour models using a site-specifically labelled PD-L1 antibody
Targeting PD-1/PD-L1 pathway in myelodysplastic syndromes and acute myeloid leukemia
The enhanced antitumor activity of bispecific antibody targeting PD-1/PD-L1 signaling
Development of a bispecific antibody targeting PD-L1 and TIGIT with optimal cytotoxicity
PD-L1 expression and the prognostic significance in gastric cancer: a retrospective comparison of three PD-L1 antibody clones (SP142, 28–8 and E1L3N)
Utility of PD-L1 immunohistochemistry assays for predicting PD-1/PD-L1 inhibitor response
Platelet PD-L1 suppresses anti-cancer immune cell activity in PD-L1 negative tumors